Tobacco.org

New study explores pulmonary rehabilitation in women with emphysema and chronic bronchitis 

New advances in pulmonary rehabilitation research are holding promise of improving the quality of life for those affected by chronic obstructive pulmonary disease, which is the nation's 4th leading cause of mortality. Harbor-UCLA Research & Education Institute (REI) principal investigator Richard Casaburi, Ph.D., M.D. is exploring anabolic drug therapy for women suffering from emphysema and chronic bronchitis, both forms of chronic obstructive pulmonary disease (COPD). Dr. Casaburi postulates that anabolic drug therapy (testosterone) can stimulate muscle growth, and improve strength in women with emphysema and chronic bronchitis. It is hoped that in the near future, this may become routine therapy for COPD patients. This study is funded by the University of California's Tobacco Related Disease Research Program.

COPD is an overwhelmingly smoking-related disease, and the only leading cause of death for which the mortality rates are rising.

Jump to full article »